Skye Bioscience, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2016 | $1.8M | $323.4K | $64.8K |
| FY2017 | $1.4M | $557.2K | $260.0K |
| FY2018 | $17.5M | $2.0M | $1.9M |
| FY2019 | $1.4M | $2.0M | $1.8M |
| FY2020 | $2.2M | $2.7M | $2.5M |
| FY2021 | $4.0M | $9.9M | $9.0M |
| FY2022 | $12.1M | $9.1M | $1.2M |
| FY2023 | $14.1M | $11.9M | $1.3M |
| FY2024 | $4.6M | $72.8M | $68.4M |
| FY2025 | $8.3M | $28.3M | $5.9M |